ENDVENDONOVO THERAPEUTICS, INC.vs its industry peers
A metric-by-metric comparison of ENDONOVO THERAPEUTICS, INC. against Electromedical & Electrotherapeutic Apparatus — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENDV본 종목 | — | — | — | — | 85.2%#3 | -495.0%#13 | -2411.7%#13 | — | — | 4#3 | — | — |
| QTI | $33M#4 | — | 5.1x#8 | 1.7x#3 | 287.9%#2 | -134.6%#11 | -23.4%#6 | -327.1%#10 | -72.2%#4 | 6#1 | 340.4%#2 | — |
| IRIX | $15M#5 | — | 3.1x#7 | 0.3x#1 | — | — | -4.9%#4 | -93.8%#6 | -90.6%#5 | — | -37.5%#6 | — |
| NXL | $8M#6 | — | 2.7x#4 | 25.6x#8 | 78.8%#4 | -8.1%#6 | -2781.7%#14 | -284.9%#8 | — | — | -61.8%#7 | — |
| NDRA | $5M#7 | — | 3.1x#6 | — | — | 38.9%#2 | — | -393.3%#11 | — | — | -12.1%#4 | — |
| NUWE | $5M#8 | 1.4x#1 | 1.9x#3 | 0.6x#2 | -5.4%#11 | -56.9%#9 | -134.3%#8 | -658.4%#12 | -171.4%#7 | — | -99.2%#9 | — |
| ADMT | — | — | — | — | 4.7%#8 | 18.4%#4 | -4.8%#3 | -17.6%#4 | -43.0%#3 | — | — | — |
| ESMC | — | — | — | — | 0.5%#10 | 184.2%#1 | 1.1%#2 | 2.5%#2 | 16.2%#1 | — | — | — |
| FOCL | $239M#2 | — | 23.6x#9 | 3.4x#5 | 1.6%#9 | -42.1%#8 | -35.0%#7 | -289.5%#9 | -137.6%#6 | 3#4 | 401.6%#1 | — |
| GTHP | — | — | — | — | 10857.1%#1 | -32.2%#7 | -309.3%#10 | — | — | 6#1 | — | — |
| HCIL | — | — | — | — | 7.1%#6 | -57.8%#10 | -13.4%#5 | -0.9%#3 | -0.8%#2 | 3#4 | — | — |
| HYPR | $100M#3 | — | 2.9x#5 | 7.4x#6 | 5.2%#7 | 12.6%#5 | -273.4%#9 | -103.5%#7 | -553.0%#8 | — | -13.1%#5 | — |
| INMD | $974M#1 | 10.7x#2 | 1.4x#2 | 2.6x#4 | -6.2%#12 | 22.5%#3 | 23.0%#1 | 29.0%#1 | — | — | 9.2%#3 | — |
| ITOC | $4M#9 | — | 0.7x#1 | 8.4x#7 | 16.7%#5 | -671.7%#14 | -991.7%#11 | -83.3%#5 | — | — | -97.8%#8 | 0.2%#1 |
| POSC | — | — | — | — | -21.5%#13 | -345.7%#12 | -2275.1%#12 | -6604.3%#13 | -3762.9%#9 | 2#6 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3845). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-08-05.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice